First‑line programmed cell death 1 inhibitor plus chemotherapy vs. standard treatment in patients with recurrent or metastatic oral squamous cell carcinoma: A retrospective cohort study.

Oncol Lett · 2024 · PMC11170260 · PMID 38872864

Europe PMC DOI

hedged sentences

0.3770

closest p · 7.5× alpha

0.3770

boldest claim

The sentences

an elevated trendP=0.377not close (p > 0.1)

In addition, the DCR exhibited an elevated trend (lacking statistical significance) in the PD-1 inhibitor + chemotherapy group compared with that in the standard treatment group (81.0 vs. 70.0%, P=0.377; Fig. 1 ).

also in 136 other papers

did not reach statistical significanceno p-value reported

70.0%, P=0.377) were numerically elevated in the PD-1 inhibitor + chemotherapy group compared with those in the standard treatment group; however, the results did not reach statistical significance.

also in 45,344 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.